|
MPHOSPH10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.369200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.559400E-01 |
| Normal-vs-Stage2 |
4.526600E-01 |
| Normal-vs-Stage3 |
9.321700E-02 |
| Normal-vs-Stage4 |
4.132600E-01 |
| Stage1-vs-Stage2 |
5.084600E-01 |
| Stage1-vs-Stage3 |
5.008400E-02 |
| Stage1-vs-Stage4 |
5.540200E-01 |
| Stage2-vs-Stage3 |
6.514400E-02 |
| Stage2-vs-Stage4 |
2.892000E-01 |
| Stage3-vs-Stage4 |
5.496400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.273600E-01 |
| Normal-vs-AfricanAmerican |
9.635800E-01 |
| Normal-vs-Asian |
1.346750E-01 |
| Caucasian-vs-AfricanAmerican |
9.824800E-01 |
| Caucasian-vs-Asian |
5.045800E-02 |
| AfricanAmerican-vs-Asian |
8.492200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.192600E-01 |
| Normal-vs-Female |
2.464200E-02 |
| Male-vs-Female |
7.170500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.007400E-01 |
| Normal-vs-Extreme_Weight |
5.017800E-01 |
| Normal-vs-Obese |
5.738000E-01 |
| Normal-vs-Extreme_Obese |
5.955600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.018200E-01 |
| Normal_Weight-vs-Obese |
7.272400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.377200E-01 |
| Extreme_Weight-vs-Obese |
2.442000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.703000E-01 |
| Obese-vs-Extreme_Obese |
6.523800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.164290E-02 |
| Normal-vs-Age(41-60Yrs) |
2.585800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.791600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.720600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.980200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.436500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.222020E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.997860E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.124990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.600800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.620800E-01 |
| Normal-VS-Type2 PRCC |
2.589200E-01 |
| Normal-VS-KIRP CIMP |
2.717600E-02 |
| Normal-VS-Unclassified PRCC |
8.408200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.640400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.799500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.156000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.922000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.098600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.191700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.849400E-01 |
| Normal-vs-N1 |
9.375200E-03 |
| Normal-vs-N2 |
4.504000E-01 |
| N0-vs-N1 |
9.443900E-04 |
| N0-vs-N2 |
9.395800E-01 |
| N1-vs-N2 |
2.663000E-03 |
|
|
